Apellis Pharmaceuticals Stock Forward View - Price Action Indicator

APLS Stock  USD 17.66  -0.06  -0.34%   
This reference view applies Price Action Indicator to Apellis Pharmaceuticals's historical closing prices. Apellis Pharmaceuticals's Price Action Indicator reference page summarizes the forecasted price and model accuracy metrics from daily trading data. Apellis Pharmaceuticals's forecast reference data is generated from the equity's historical trading prices. Mean absolute deviation and related metrics help quantify forecast uncertainty for Apellis Pharmaceuticals.
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997. All forecast values on this page for Apellis Pharmaceuticals are Price Action Indicator reference data derived from historical price series.

Price Action Indicator Analysis Today

Apellis Pharmaceuticals has current Price Action Indicator of -0.03. Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.
VolatilityBacktestInformation Ratio  

Apellis Pharmaceuticals Trading Date Momentum

On March 26 2026 Apellis Pharmaceuticals was traded for 17.66 at the closing time. The top price for the day was 17.66 and the lowest listed price was 17.66 . There was no trading activity during the period. Lack of trading volume on March 26, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.34% .
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Apellis Pharmaceuticals to competition

Other Forecasting Options for Apellis Pharmaceuticals

Volume-weighted price analysis for Apellis Stock gives heavier weight to price levels where trading activity was highest. Crossovers in the MACD line and signal line can identify shifts in Apellis momentum before they appear in raw price. Comparing Apellis Pharmaceuticals' realized volatility to implied volatility reveals whether the options market expects larger or smaller moves. Readings above 80 or below 20 highlight potential reversal zones in Apellis Stock price action.

Apellis Pharmaceuticals Related Equities

These firms work in a similar space as Apellis Pharmaceuticals within the Health Care space and serve as useful points for comparison. Checking Apellis Pharmaceuticals against peers on P/E, margins, and return on equity helps put its position in context.
 Risk & Return  Correlation

Apellis Pharmaceuticals Market Strength Events

Evaluating the market strength of Apellis Pharmaceuticals stock allows investors to gauge shifts in market momentum. Monitoring these indicators highlights periods where Apellis Pharmaceuticals trading conditions shift meaningfully. These metrics are particularly useful when Apellis Pharmaceuticals stock shows divergence from broader market trends. Regularly reviewing Apellis Pharmaceuticals strength signals helps maintain a structured approach to position management.

Apellis Pharmaceuticals Risk Indicators

Understanding Apellis Pharmaceuticals' risk indicators is essential for any investor seeking to forecast its future price accurately. By identifying how much risk is embedded in Apellis Pharmaceuticals' investment, investors can decide how to position their exposure. Reviewing Apellis Pharmaceuticals' basic risk indicators is essential for managing investment risk effectively. The risk-return trade-off for apellis stock becomes clearer when Apellis Pharmaceuticals' risk indicators are properly assessed.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Apellis Pharmaceuticals

A coverage review of Apellis Pharmaceuticals shows when the security is attracting above-average attention from contributors and market observers. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.

Apellis Pharmaceuticals Short Properties

Short-interest signals around Apellis Pharmaceuticals can help investors judge whether skeptical positioning is starting to pressure price predictability and market tone. This is most valuable when investors want to know whether bearish pressure is starting to shape the market's reaction function.
Common Stock Shares Outstanding126 M
Cash And Short Term Investments467.8 M

Additional Tools for Apellis Stock Analysis

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Holdings
Check your current holdings and cash position to determine if your portfolio needs rebalancing
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Commodity Directory
Find actively traded commodities issued by global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites